Identification of agents, particularly natural endogenous biologicals, which stimulate alternative non-CFTR Cl− secretory pathways and promote ASL hydration and recovery of optimal ASL height are likely to be of therapeutic benefit in improving mucociliary clearance in patients with CF. Here, CFTR is linked to cystic fibrosis.